Idexx Laboratories Inc IDXX
Analyst Ratings
- Consensus
- Moderate Buy — 5 Buy · 3 Hold · 0 Sell (8 analysts)
- Avg. Price Target
- $731.88 (+43.0% upside)
Key Stats
- Today's Range
- $505.21 – $516.43
- 50-Day Range
- $500.61 – $624.15
- 52-Week Range
- $500.61 – $769.98
- Volume
- 1.12 million shs
- Average Volume
- 521K shs
- Market Cap
- $39.90 billion
- P/E Ratio
- 35.96
- Dividend Yield
- —
Valuation
- P/E Ratio
- 35.96
- Price / Book
- 24.74
- Price / Sales
- 8.76
Short Interest
- Short Interest
- 1.79%
- Days to Cover
- 4.37
Financials (TTM)
- Revenue
- $4.55 billion
- Net Income
- $1.14 billion
- Net Margin
- 25.03%
- Return on Equity
- 70.67%
- Debt-to-Equity
- —
About Idexx Laboratories Inc
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Related Stocks
Compare head-to-head: IDXX vs LNTH·IDXX vs CLDX·IDXX vs NTLA·IDXX vs QDEL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.